Impact of the addition of carboplatin to anthracycline‐taxane‐based neoadjuvant chemotherapy on survival in <i>BRCA1/2</i>‐mutated triple‐negative breast cancer
Juan Zhang(Central South University), Yuntao Xie(Peking University), Zhaoqing Fan(Daqing Oilfield General Hospital), Tianfeng Wang(Harbin Medical University), Tao Ouyang(Ministry of Education), Tie Fan(Ministry of Education), Yiqiang Liu(Ministry of Education), Lu Yao(Tianjin Medical University Cancer Institute and Hospital), Benyao Lin(Ministry of Education), Jinfeng Li(Hebei Medical University)
Cited by 23
Related Papers
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
|Medicinal Research Reviews|2015|181